Insights Gained From the <scp>PPMI</scp> Brain Donation Program

Brain autopsy plays a critical role advancing understanding of neurological conditions, providing unique insights that may otherwise not be captured through studies of living individuals. In addition, given our increasing reliance on biomarkers of disease biology, pathology is the gold standard to validate biomarkers showing that early evidence of disease biology is consistent with postmortem pathology. Postmortem tissue collection is challenging, and opportunities to correlate neuropathological findings with longitudinal clinical, genetic, imaging, and biomarker data are often limited. The Parkinson's Progression Markers Initiative study demonstrates how centralized brain donation leads to a higher number of successful tissue collections. Summarized findings from study cases highlight how neuropathology enhances disease characterization and how plans to implement new and innovative methods for neuropathological analysis will advance the field. ANN NEUROL 2026.

Authors

Institutions

Publication Details

Journal
Annals of Neurology
Published
2026-04-26
DOI
https://doi.org/10.1002/ana.78229
Primary Topic
Organ Donation and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Insights Gained From the PPMI Brain Donation Program

Kathleen L. Poston, Malia Rumbaugh, Gena Antonopoulos, Christine L. Mac Donald et al.
Annals of Neurology
Organ Donation and Transplantation
article

Insights Gained From the PPMI Brain Donation Program

Kathleen L. Poston, Malia Rumbaugh, Gena Antonopoulos, Christine L. Mac Donald, C. Dirk Keene, Tom Montine, Laura E. A. Heathers, Kenneth Marek, the Parkinson's Progression Markers Initiative, Caitlin S. Latimer, Kumar Mantravadi, Tatiana Foroud, Syed Bukhari, Thomas F. Tropea
article en

Abstract

Brain autopsy plays a critical role advancing understanding of neurological conditions, providing unique insights that may otherwise not be captured through studies of living individuals. In addition, given our increasing reliance on biomarkers of disease biology, pathology is the gold standard to validate biomarkers showing that early evidence of disease biology is consistent with postmortem pathology. Postmortem tissue collection is challenging, and opportunities to correlate neuropathological findings with longitudinal clinical, genetic, imaging, and biomarker data are often limited. The Parkinson's Progression Markers Initiative study demonstrates how centralized brain donation leads to a higher number of successful tissue collections. Summarized findings from study cases highlight how neuropathology enhances disease characterization and how plans to implement new and innovative methods for neuropathological analysis will advance the field. ANN NEUROL 2026.

Annals of Neurology
Palo Alto University (US), University of Washington (US), Institute for Neurodegenerative Disorders (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), University of Pennsylvania (US), Stanford University (US)
Openalex Percentile: Top 10%
Organ Donation and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.